Balancing Speed and Evidence in Developing Covid-19 Therapies

Nov 5, 2020

Virtual Symposium

slides and recordings

• Thomas Jaki - Designing efficient clinical trials during a pandemic (slides)

• Julia Niewczas - Statistical challenges of designing Covid-19 therapeutic and prophylaxis studies (slides)

• Natasha Muhlemann & Rajat Mukherjee - A bayesian sequential design for Covid-19 vaccine trials (slides)

• Hemal B. Mehta - Clinical trials for Covid-19: Speed and efficiency (slides)